< Back to Results

Primary Contact Name
Joseph Maakaron
Primary Contact Email Address
maaka001@umn.edu
Primary Contact Phone Number
612-624-5109
Program Name
University of Minnesota - Blood & Marrow Transplant & Cellular Therapies Fellowship (BMT-CT)
Address
420 Delaware St. SE, MMC #480
Minneapolis, MN, 55455
Website
https://med.umn.edu/dom/education/fellowships/blood-marrow-transplant-cellular-therapies-fellowship
Program Director/Fellowship Director
Joseph Maakaron
Program Director/Fellowship Director Email
maaka001@umn.edu
Is the primary focus of your program on Blood and Marrow Transplantation (BMT) or Cellular Therapies?
BTH
How long is the Fellowship program at your institution?
One Year
How long is the BMT Fellowship program at your institution?
Not Provided
Option to extend training or research if funding is available?
No
Is the primary focus of your program on adult or pediatric populations?
Adult
How long before the Fellowship start date should applicants apply?
7-12 Months
When does your Fellowship application period begin?
September
When does your Fellowship application period end?
December
Interview required?
Yes
Interview Format
Virtual
How many training spaces?
Two
If you selected other, how many training spaces are there?
Not Provided
When does your program typically start?
July
If flexible, please describe
Not Provided
Visa Sponsorship?
Yes
If you selected yes, please specify the type of visa
J1, H1B
What are the requirements for fellows applying to your program?
Completion of residency training (Board Certified) or equivalent abroad, Completion of Hematology and/or Oncology Fellowship or equivalent (Board Eligible), ECFMG certification if IMG applicant
If you selected other, please explain
Not Provided
Are there any unique training opportunities in your fellowship program? (For example: rotation with CTRM, H&I Lab, exposure to CAR T Therapy, etc.)
The curriculum includes inpatient and outpatient BMT&CT training, specific training in clinical laboratory and ancillary training in cell processing, donor screening, apheresis, management of complications (e.g., graft-versus-host disease, cytokine release syndrome, and neurotoxicity), blood product support, and transplant immunology, and research training.
Continuity Clinic with trainee as primary physician with supervision?
Yes
Approximate volume of cases at your center for the following
Autologous Transplant
Not Provided
Allogeneic Transplant
Not Provided
CAR T
Not Provided
Approximate Structure (In weeks)
Inpatient
Not Provided
Outpatient/Consults
Not Provided
Research
Not Provided
Lab-Based
Not Provided
Other (specify)
Not Provided
Sample Schedule Upload
Not Provided
Educational Stipend/Conference funding available:
Yes - Specify
Specify the Educational Stipend/Conference funding available
Not Provided
If you were interested in the standard time frame, what part of the process would you be interested in standardizing?
Not Provided

< Back to Results